Institut für Virologie, Freie Universität Berlin, Berlin, Germany.
Department of Biological Sciences, University of Delaware, Newark, United States of America.
PLoS Pathog. 2020 Dec 11;16(12):e1009104. doi: 10.1371/journal.ppat.1009104. eCollection 2020 Dec.
Modified-live herpesvirus vaccines are widely used in humans and animals, but field strains can emerge that have a higher virulence and break vaccinal protection. Since the introduction of the first vaccine in the 1970s, Marek's disease virus overcame the vaccine barrier by the acquisition of numerous genomic mutations. However, the evolutionary adaptations in the herpesvirus genome responsible for the vaccine breaks have remained elusive. Here, we demonstrate that point mutations in the multifunctional meq gene acquired during evolution can significantly alter virulence. Defined mutations found in highly virulent strains also allowed the virus to overcome innate cellular responses and vaccinal protection. Concomitantly, the adaptations in meq enhanced virus shedding into the environment, likely providing a selective advantage for the virus. Our study provides the first experimental evidence that few point mutations in a single herpesviral gene result in drastically increased virulence, enhanced shedding, and escape from vaccinal protection.
改良活疱疹病毒疫苗在人类和动物中被广泛应用,但可能会出现毒力更高并突破疫苗保护的野外毒株。自 20 世纪 70 年代推出第一种疫苗以来,马立克氏病病毒通过获得大量基因组突变克服了疫苗障碍。然而,疱疹病毒基因组中导致疫苗突破的进化适应仍然难以捉摸。在这里,我们证明了在进化过程中获得的多功能 meq 基因中的点突变可以显著改变毒力。在高毒力毒株中发现的定义明确的突变也允许病毒克服先天细胞反应和疫苗保护。同时,meq 的适应增强了病毒向环境中的脱落,这可能为病毒提供了选择优势。我们的研究首次提供了实验证据,表明单个疱疹病毒基因中的少数点突变会导致毒力急剧增加、脱落增强,并逃避疫苗保护。